human cd44s pan specific antibody Search Results


antibodies against cd44  (R&D Systems)
97
R&D Systems antibodies against cd44
Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, <t>CD44</t> or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.
Antibodies Against Cd44, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against cd44/product/R&D Systems
Average 97 stars, based on 1 article reviews
antibodies against cd44 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
anti cd44 pan  (R&D Systems)
93
R&D Systems anti cd44 pan
Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, <t>CD44</t> or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.
Anti Cd44 Pan, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd44 pan/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti cd44 pan - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti cd44  (R&D Systems)
93
R&D Systems anti cd44
Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, <t>CD44</t> or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.
Anti Cd44, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd44/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti cd44 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cd44  (R&D Systems)
90
R&D Systems cd44
Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, <t>CD44</t> or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.
Cd44, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd44/product/R&D Systems
Average 90 stars, based on 1 article reviews
cd44 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd44 pe  (R&D Systems)
91
R&D Systems cd44 pe
Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, <t>CD44</t> or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.
Cd44 Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd44 pe/product/R&D Systems
Average 91 stars, based on 1 article reviews
cd44 pe - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
apc conjugated mouse anti human  (R&D Systems)
86
R&D Systems apc conjugated mouse anti human
Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, <t>CD44</t> or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.
Apc Conjugated Mouse Anti Human, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc conjugated mouse anti human/product/R&D Systems
Average 86 stars, based on 1 article reviews
apc conjugated mouse anti human - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

Image Search Results


Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, CD44 or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.

Journal: Cell Death Discovery

Article Title: MUC1 O -glycosylation contributes to anoikis resistance in epithelial cancer cells

doi: 10.1038/cddiscovery.2017.44

Figure Lengend Snippet: Effect of shRNA C1GT suppression on antibody accessibility to cell surface anoikis-initiating molecules. The shRNA C1GT transfected or shRNA control cells from the MUC1- positive F3 cells were incubated with antibodies against E-cadherin, integrin β 1, CD44 or Fas. After washing and application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean florescence intensity of the antibody binding are shown in b . Cells were also lysed and analysed by immunoblotting ( c ) for the expression of these molecules with the same antibodies as in a . ** P <0.01, *** P <0.001.

Article Snippet: Antibodies against CD44 (BBA10), integrin β 1 (MAB17782), E-cadherin (MAB1838), Fas (AF2267) and Fas-L (AF126) were from R&D Systems (Abingdon, UK).

Techniques: shRNA, Transfection, Control, Incubation, Flow Cytometry, Expressing, Binding Assay, Western Blot

Effect of shRNA C1GT suppression increases antibody accessibility to cell surface anoikis-initiating molecules and enhances Fas-L-induced caspase-8 activity in SW620 cells. shRNA C1GT transfected or shRNA control transfected SW620 cells were incubated with antibodies against E-cadherin, integrin β 1, CD44 or Fas. After application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean (±S.D.) florescence intensity of the antibody bindings are shown in b . Cells were also lysed and analysed for the expression of these molecules by immunoblotting with the same antibodies ( c ). In d , the shRNA control and shRNA C1GT transfected SW620 cells were cultured in the presence or absence of 100 ng/ml recombinant Fas-L in suspension and the cell caspase-8 activity was determined after 2 h by Caspase-8-Glo kit. Data are expressed as mean±S.E.M. of triplicate determination of three experiments, *** P <0.001.

Journal: Cell Death Discovery

Article Title: MUC1 O -glycosylation contributes to anoikis resistance in epithelial cancer cells

doi: 10.1038/cddiscovery.2017.44

Figure Lengend Snippet: Effect of shRNA C1GT suppression increases antibody accessibility to cell surface anoikis-initiating molecules and enhances Fas-L-induced caspase-8 activity in SW620 cells. shRNA C1GT transfected or shRNA control transfected SW620 cells were incubated with antibodies against E-cadherin, integrin β 1, CD44 or Fas. After application of FITC-conjugated secondary antibody, the cells were analysed by flow cytometry ( a , solid and dotted lines show the peak positions of control and shRNA C1GT transfected cells, respectively. Dotted line shifted to the left or right of the solid line reveals reduction or increase of molecule expression). Mean (±S.D.) florescence intensity of the antibody bindings are shown in b . Cells were also lysed and analysed for the expression of these molecules by immunoblotting with the same antibodies ( c ). In d , the shRNA control and shRNA C1GT transfected SW620 cells were cultured in the presence or absence of 100 ng/ml recombinant Fas-L in suspension and the cell caspase-8 activity was determined after 2 h by Caspase-8-Glo kit. Data are expressed as mean±S.E.M. of triplicate determination of three experiments, *** P <0.001.

Article Snippet: Antibodies against CD44 (BBA10), integrin β 1 (MAB17782), E-cadherin (MAB1838), Fas (AF2267) and Fas-L (AF126) were from R&D Systems (Abingdon, UK).

Techniques: shRNA, Activity Assay, Transfection, Control, Incubation, Flow Cytometry, Expressing, Western Blot, Cell Culture, Recombinant, Suspension